Browse All

Current Filters

CLEAR FILTER x

TITLE

Topic:

Treatment with Eptinezumab Reduces Brain Fog and Increases the Number of Good Days Per Month in Patients with Chronic Migraine in a Real-world Setting

Author:Buse, Dawn   Soni-Brahmbhatt, Seema   Asher, Divya   Lipton, Richard B.   

Session Name:P8: Headache: Advances in CGRP Inhibition 2  

Topic:Headache  

Program Number:P8.009  

Author Institution:Albert Einstein College of Medicine, Bronx, NY  Lundbeck LLC, Deerfield, IL  

A Headache for a Headache: Variability in Prior Authorizations as a Bottleneck for Patient Access to CGRP-modulating Medications to Treat Migraine

Author:Yan, Anthony   Challagundla, Sankeerth   

Session Name:P8: Headache: Advances in CGRP Inhibition 2  

Topic:Headache  

Program Number:P8.010  

Author Institution:Prisma Health-Midlands/University of South Carolina School of Medicine, Columbia, SC  

Acute Treatment of Migraine with Zavegepant Nasal Spray Reduces the Use of Select Analgesics

Author:Kudrow, David   Mosher, Linda   Straghan, Esther   Sweeney, Samantha   Fountaine, Robert   

Session Name:P9: Headache: Advances in CGRP Inhibition 3  

Topic:Headache  

Program Number:P9.001  

Author Institution:The Los Angeles Headache Center, Los Angeles, CA  Pfizer Inc, Groton, CT  Pfizer Inc, New York, NY  

The Safety and Efficacy of Dual Calcitonin Gene-related Peptide Therapies for Migraine Treatment

Author:Lee, Ho Hyun   Yoshioka, Reyn   Woo, Man Ian   Liquard, Lana   Jahansooz, Julia   Weldon, Edward   Lee, Anson   Ishikawa, Kyle   Little, Nicole   Carrazana, Enrique   Viereck, Jason   Liow, Kore   

Session Name:P9: Headache: Advances in CGRP Inhibition 3  

Topic:Headache  

Program Number:P9.002  

Author Institution:John A. Burns School of Medicine, Honolulu, HI  University of San Diego, San Diego, CA  University of Hawaii at Manoa, Honolulu, HI  McGill University, Montreal, QC, Canada  Hawaii Pacific Neuroscience, Honolulu, HI  

Interictal Burden Before Initiating Calcitonin Gene-related Peptide Monoclonal Antibody for Migraine Prevention

Author:Vincent, Maurice   Hoyt, Margaret   Lenderking, William R.   Hetherington, Lucinda   Ruff, Dustin   Kim, Gilwan   Viktrup, Lars   

Session Name:P9: Headache: Advances in CGRP Inhibition 3  

Topic:Headache  

Program Number:P9.003  

Author Institution:Eli Lilly and Company, Indianapolis, IN  Evidera, Bethesda, MD  Evidera, London, United Kingdom